SUPN
Supernus Pharmaceuticals
$46.98
+$0.78 (+1.69%)Jul 27, 2026
Key metrics
The numbers that frame SUPN today
- Market cap
- $2.73B
- P/E (TTM)
- -94.0
- EV / FCF
- 31.3
- Gross margin
- 89.4%
- EV / Sales
- 3.3
- ROIC
- -16.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $32.53
- 52wk High
- $59.68
Growth
Revenue and earnings trend for SUPN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SUPN
Is Supernus Pharmaceuticals a good buy?
Yes. Supernus Pharmaceuticals has strong quality and mixed momentum. Taken together, the setup leans positive. Growth looks strong, which supports the long-term business case. We think Supernus Pharmaceuticals is selling at a fair price.
What is the market capitalization of SUPN?
Supernus Pharmaceuticals's market capitalization is $2.73B.
What is the P/E ratio for SUPN stock?
Supernus Pharmaceuticals's current P/E ratio is -94.
What is the 52-week high for SUPN stock?
The 52-week high for Supernus Pharmaceuticals is $59.68. The current close of $46.98 is 21.3% below that high.
What is the 52-week low for SUPN stock?
The 52-week low for Supernus Pharmaceuticals is $32.53. The current close of $46.98 is 44.4% above that low.
Does SUPN stock pay dividends?
Supernus Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SUPN?
Supernus Pharmaceuticals's Debt / Equity ratio is 0.03.